28 results on '"Uyl-de Groot Carin A"'
Search Results
2. Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative
3. Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands
4. A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model
5. Real-world costs of laboratory tests for non-small cell lung cancer
6. A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
7. PREDICTION OF CARE BURDEN OF PATIENTS UNDERGOING HAEMODIALYSIS: DEVELOPMENT OF A MEASURING TOOL
8. Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study
9. Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study
10. Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence
11. The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia
12. Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value
13. Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
14. Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: The influence of new medication and diagnostic technology
15. Reducing Disparities in Breast Cancer Survival – The Effect of Large-Scale Screening of the Uninsured
16. Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia
17. The Unit Costs of Inpatient Hospital Days, Outpatient Visits, and Daycare Treatments in the Fields of Oncology and Hematology
18. Incorporating Equity–Efficiency Interactions in Cost-Effectiveness Analysis—Three Approaches Applied to Breast Cancer Control
19. The economics of improved cancer survival rates: better outcomes, higher costs
20. Cost–effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme
21. Cost-Effectiveness of Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Report From the Eortc 26981/22981 Nci-C Ce3 Intergroup Study
22. The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale
23. Traditional Versus Up-Front [18F] Fluorodeoxyglucose–Positron Emission Tomography Staging of Non–Small-Cell Lung Cancer: A Dutch Cooperative Randomized Study
24. Costs and Health Effects of Breast Cancer Interventions in Epidemiologically Different Regions of Africa, North America, and Asia
25. Costs of multiple myeloma and associated skeletal-related events in The Netherlands
26. Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkinʼs Lymphoma
27. Treatment Costs and Quality of Life with Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Antineoplastic Therapy-Related Febrile Neutropenia: Results of a Randomised Placebo-Controlled Trial
28. Colony-Stimulating Factors and Peripheral Blood Progenitor Cell Transplantation: Benefits and Costs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.